Search PDMR transactions

Notifier
Name
Leo Cornelis Groenewegen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Leo Cornelis Groenewegen
Position
Chief Financial Officer
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
NextCell Pharma
LEI code
549300PBFGB5JYKXGA45
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
NextCell Pharma SE0009723125 Acquisition 15,000 Quantity 6.00 SEK 27/12/2017 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
NextCell Pharma SE0009723125 Acquisition 27/12/2017 Outside a trading venue 15,000 (Quantity) 6.00 SEK
<< Back